androstenediol has been researched along with Injuries, Radiation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, T; Guo, W; Liu, W; Wu, T; Zhong, H; Zhou, H; Zhu, X | 1 |
| Romaine, PL; Seed, TM; Singh, VK | 1 |
| Ben-Nathan, D; Carter, H; Conrad, DH; Huff, T; Loria, RM | 1 |
| Elliott, TB; Jackson, WE; Kumar, KS; Landauer, MR; Ledney, GD; Mckinney, L; Seed, TM; Srinivasan, V; Whitnall, MH; Wilhelmsen, CL | 1 |
| Kluger, J | 1 |
1 review(s) available for androstenediol and Injuries, Radiation
| Article | Year |
|---|---|
Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.
Topics: Amifostine; Androstenediol; Animals; Drug Approval; Granulocyte Colony-Stimulating Factor; Humans; Metalloporphyrins; Peptides; Radiation Injuries; Radiation-Protective Agents; Strategic Stockpile; United States; United States Food and Drug Administration | 2015 |
4 other study(ies) available for androstenediol and Injuries, Radiation
| Article | Year |
|---|---|
5-Androstenediol prevents radiation injury in mice by promoting NF-κB signaling and inhibiting AIM2 inflammasome activation.
Topics: Anabolic Agents; Androstenediol; Animals; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Inflammasomes; Mice; Mice, Inbred C57BL; NF-kappa B; Radiation Injuries; Radiation-Protective Agents; Signal Transduction | 2020 |
Androstenetriol and androstenediol. Protection against lethal radiation and restoration of immunity after radiation injury.
Topics: Anabolic Agents; Androstenediol; Animals; Immunity; Male; Mice; Mice, Inbred C57BL; Neuroimmunomodulation; Radiation Injuries | 2000 |
In vivo protection against gamma-irradiation with 5-androstenediol.
Topics: Androstenediol; Animals; Female; Gamma Rays; Killer Cells, Natural; Leukocyte Count; Male; Mice; Monocytes; Neutropenia; Radiation Injuries; Radiation-Protective Agents; Thrombocytopenia; Whole-Body Irradiation | 2001 |
Is this the next Cipro? Not quite.
Topics: Androstenediol; Disaster Planning; Government Agencies; Humans; Potassium Iodide; Radiation Injuries; Radioactive Hazard Release; Terrorism; United States | 2001 |